10x Genomics
311 hedge funds and large institutions have $6.29B invested in 10x Genomics in 2022 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 133 increasing their positions, 71 reducing their positions, and 96 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
35% less call options, than puts
Call options by funds: $20.5M | Put options by funds: $31.7M
47% less capital invested
Capital invested by funds: $11.9B → $6.29B (-$5.58B)
48% less first-time investments, than exits
New positions opened: 50 | Existing positions closed: 96
Holders
311
Holding in Top 10
8
Calls
$20.5M
Puts
$31.7M
Top Buyers
| 1 | +$338M | |
| 2 | +$117M | |
| 3 | +$86.6M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$55.6M |
| 5 |
1WCM
12 West Capital Management
New York
|
+$39.1M |
Top Sellers
| 1 | -$239M | |
| 2 | -$233M | |
| 3 | -$159M | |
| 4 |
JCM
JS Capital Management
New York
|
-$80.5M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$59.4M |